Waltham, MA, United States of America

Gary Palmer

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Fort Lauderdale, FL (US) (2015)
  • Waltham, MA (US) (2018 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Gary Palmer: Innovator in Cancer Treatment Technologies

Introduction

Gary Palmer is a notable inventor based in Waltham, MA (US), recognized for his contributions to cancer treatment technologies. With a total of seven patents to his name, Palmer has made significant strides in the field of oncology through innovative systems and methods.

Latest Patents

Among his latest patents is a groundbreaking invention related to estrogen receptor mutations. This patent discloses novel mutant ESR1 molecules and their various uses. Another significant patent focuses on a system and method for outcome tracking and analysis. This system captures outcome information associated with various cancer treatments, facilitating the analysis of treatment data and genomic alterations. The system is designed to store and analyze information related to tumor types, genomic alterations, and treatment data, ultimately aiding in diagnosis and therapy decisions.

Career Highlights

Throughout his career, Gary Palmer has worked with prominent companies in the healthcare sector, including Foundation Medicine, Inc. and MTS Holdings, Inc. His work has been pivotal in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Palmer has collaborated with esteemed colleagues such as Vincent A. Miller and Philip James Stephens, contributing to the development of innovative solutions in cancer treatment.

Conclusion

Gary Palmer's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment technologies. His patents and collaborations reflect a commitment to improving patient care through advanced research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…